Hereditary Angioedema with Normal C1 Inhibitor Update on Evaluation and Treatment

被引：43

作者：

Magerl, Markus ^{[1
]}

Germenis, Anastasios E. ^{[2
]}

Maas, Coen ^{[3
]}

Maurer, Marcus ^{[1
]}

机构：

[1] Charite Univ Med Berlin, Dept Dermatol & Allergy, Allergie Centrum Charite ECARF, Charitepl 1, D-10117 Berlin, Germany

[2] Univ Thessaly, Sch Hlth Sci, Fac Med, Dept Immunol & Histocompatibil, Panepistimiou 3, GR-41500 Biopolis, Larissa, Greece

[3] Univ Med Ctr Utrecht, Dept Clin Chem & Haematol, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands

来源：

IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA | 2017年 / 37卷 / 03期

关键词：

Hereditary angioedema; Factor XII; Plasmin; Mutation; Bradykinin; C1-inhibitor; FACTOR-XII GENE; CONTACT SYSTEM ACTIVATION; ANGIONEUROTIC-EDEMA; PRODROMAL SYMPTOMS; HAGEMAN-FACTOR; F12; GENE; PLASMINOGEN-ACTIVATOR; IDIOPATHIC ANGIOEDEMA; PATHOGENIC MECHANISMS; MISSENSE MUTATIONS;

D O I：

10.1016/j.iac.2017.04.004

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

A new form of hereditary angioedema (HAE) was identified in the year 2000. Its clinical appearance resembles HAE types I and II, which are caused by mutations that result in low levels of C1 inhibitor (C1-INH). In patients with this form of HAE, C1-INH plasma levels and function values are normal, so it is termed HAE with normal C1-INH (HAE-nC1). HAE-nC17 in a subgroup of patients, is thought to be caused by mutations that affect the F12 gene. The diagnosis of HAE-nC1 is based on history and clinical criteria. There are no licensed drugs with proven treatment effects for HAE-nC1.

引用

页码：571 / +

页数：15

共 50 条

[1] Diagnosis and treatment of hereditary angioedema with normal C1 inhibitor
Konrad Bork
[J]. Allergy, Asthma & Clinical Immunology, 6 (1)
[2] Normal C1 Inhibitor Hereditary Angioedema
Kittisupamongkol, Weekitt
[J]. AMERICAN JOURNAL OF MEDICINE, 2009, 122 (05): : E7 - E7
[3] Hereditary Angioedema with Normal C1 Inhibitor
Bork, Konrad
[J]. IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2013, 33 (04) : 457 - +
[4] Hereditary angioedema with normal C1 inhibitor
Bork, Konrad
[J]. IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2010, 30 : 20 - 28
[5] Hereditary Angioedema with Normal C1 Inhibitor
Patel, Nilesh N.
Patel, Devesh N.
[J]. AMERICAN JOURNAL OF MEDICINE, 2008, 121 (11): : 949 - 951
[6] Treatment of Patients with Hereditary Angioedema with Normal C1 Inhibitor: Evaluation of 295 Patients
Fragnan, Nyla T. M. L.
Veronez, Camila
Moreno, Adriana
Arruda, Luisa Karla P.
Goncalves, Rozana F.
Valle, Solange
Almeida, Stephanie K. A.
Dortas, Sergio D., Jr.
Alonso, Maria Luiza
Mansour, Eli
Serpa, Faradiba Sarquis
Giavina-Bianchi, Pedro
Takejima, Priscila
Chong Neto, Herberto J.
Rosario, Nelson Augusto
Campos, Regis De Albuquerque
Silva, Jane
Toledo, Eliana C.
Dias, Gabriela A. C.
Ferraroni, Natasha R.
Piccirilo, Miguel
Bernardes, Marli S.
Constantino-Silva, Rosemeire N.
Pesquero, Joao B.
Grumach, Anete S.
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (02) : AB41 - AB41
[7] C1 inhibitor for treatment of hereditary angioedema
Frank, Michael M.
[J]. IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2010, 30 : 50 - 57
[8] Normal C1 Inhibitor Hereditary Angioedema Reply
Patel, Nilesh N.
Patel, Devesh N.
[J]. AMERICAN JOURNAL OF MEDICINE, 2009, 122 (05): : E9 - E9
[9] Update in hereditary angioedema due to C1 inhibitor deficiency
Guilarte, Mar
[J]. MEDICINA CLINICA, 2012, 139 (10): : 452 - 457
[10] Pregnancy in Patients With Hereditary Angioedema and Normal C1 Inhibitor
Gabriel, Natalia
Marcelino, Fernanda
Ferriani, Mariana P. L.
Arruda, L. Karla
Campos, Regis A.
Goncalves, Rozana F.
Chong-Neto, Herberto
Rosario Filho, Nelson
Valle, Solange O. R.
Pesquero, Joao B.
Grumach, Anete S.
[J]. FRONTIERS IN ALLERGY, 2022, 3

← 1 2 3 4 5 →